MANGOCEUTICALS, INC. — Form 8-K
Filed July 2, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 22/100
What the filing says
Mangoceuticals, Inc. filed a subscription agreement for a Regulation D private placement (Section 4(a)(2) and Rule 506(b)) with no minimum raise, no closing timeline requirement, and immediate use of proceeds. Purchase price is $0.32 per share of common stock. The offering targets accredited investors only; no specific dollar cap, share count, or counterparties are named in this template document. Piggyback registration rights expire one year from acceptance; shares are restricted and subject to resale limitations.
Why this rating
Boilerplate private offering template with no committed capital, named investors, or defined fundraising target disclosed. At $14.7M market cap, any capital raised could be material, but absence of concrete terms makes impact assessment speculative. Standard administrative filing.
View original filing on SEC.gov ↗
See more from July 2, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.